← Back to Search
Chemical Synthesis Of Monodisperse Magnetic Nanoparticles For Sensitive Cancer Detection
Published 2013 · Materials Science
Download PDFAnalyze on Scholarcy
This short tutorial review highlights the advance in high temperature solution phase chemical synthesis of monodisperse magnetic nanoparticles (MNPs), especially iron oxide NPs, as contrast enhancement agents for cancer detection by magnetic resonance imaging (MRI). It introduces briefly the unique nanomagnetism of MNPs required for MRI. It then summarizes some typical methods used to prepare monodisperse Fe3O4 and ferrite MFe2O4 MNPs from high temperature organic phase reaction with controlled magnetic properties. It further outlines the chemistry used to make these MNPs biocompatible and target-specific. Finally it presents two examples to demonstrate the MNP control achieved from chemical synthesis for sensitive detection of cancer.
This paper references
Magnetic nanoparticles as both imaging probes and therapeutic agents.
Lise-Marie Lacroix (2010)
Zinc ferrite nanoparticles as MRI contrast agents.
C. Bárcena (2008)
Perceptions of Herceptin: a monoclonal antibody for the treatment of breast cancer.
R. Dillman (1999)
High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
Eric J. Werner (2008)
Kraitchman, Iron oxide MR contrast agents for molecular and cellular imaging
D.L.J.W. Bulte (2004)
Brougham, Stable aqueous dispersions of glycopeptide-grafted selectably functionalized magnetic nanoparticles
T. Borase (2013)
Stable aqueous dispersions of glycopeptide-grafted selectably functionalized magnetic nanoparticles.
Tushar Borase (2013)
Ultra-large-scale syntheses of monodisperse nanocrystals
J. Park (2004)
Expert heads a'rolling
J. Leach (2005)
b without NPs, c with the injection of 300 lg of c(RGDyK)-MC-Fe3O4 NPs; d Prussian blue staining of U87MG tumors in the presence of c(RGDyK)-MC-Fe3O4 NPs
MRI Principles Fig. 5 a Schematic illustration of the D.G. Mitchell (2014)
Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.
P. Caravan (2006)
RGD and integrins
E. Ruoslahti (1987)
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).
M. Leach (2005)
One-nanometer-scale size-controlled synthesis of monodisperse magnetic iron oxide nanoparticles.
J. Park (2005)
Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects.
L. Stabile (2005)
Kellar, Theory of 1/T-1 and 1/T-2 Nmrd profiles of solutions of magnetic nanoparticles
K.E.S.H. Koenig (1995)
New perspectives in cell adhesion: RGD and integrins.
E. Ruoslahti (1987)
New forms of superparamagnetic nanoparticles for biomedical applications.
C. Xu (2013)
Antibodies cut down to size
R. C. Ladner (2007)
Magnetic nanoparticles for multi-imaging and drug delivery
Jae-Hyun Lee (2013)
Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer
W. Pao (2010)
Iron oxide MR contrast agents for molecular and cellular imaging
J. Bulte (2004)
Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer.
M. Goldenberg (1999)
Ultrasmall c(RGDyK)-coated Fe3O4 nanoparticles and their specific targeting to integrin alpha(v)beta3-rich tumor cells.
Jin Xie (2008)
Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model.
W. Arap (1998)
Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging
Jaehyun Lee (2007)
Size-controlled synthesis of magnetite nanoparticles.
S. Sun (2002)
Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application.
Y. Wáng (2011)
Size-controlled synthesis of magnetite nanoparticies
S. H. Sun (2002)
Synthesis, Properties and Applications Ch
K M. Unruh (1996)
a monoclonal antibody for the treatment of breast cancer
R. O. Dillman (1999)
Synthesis and Characterization of Monodisperse Nanocrystals and Close-Packed Nanocrystal Assemblies
C. Murray (2000)
current status of clinical application
Y.-X.J. Wang (2011)
Magnetic nanoparticles as contrast agents in the diagnosis and treatment of cancer.
J. Gallo (2013)
Introduction to Magnetic Materials (Addison Wesley Publishing
B. D. Cullity (1972)
Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles.
S. Sun (2004)
TOPICAL REVIEW: Applications of magnetic nanoparticles in biomedicine
Q. Pankhurst (2003)
Monodisperse MFe 2 O 4 ( M ) Fe , Co , Mn ) Nanoparticles
A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor
A. Jungbluth (2003)
αv Integrins as receptors for tumor targeting by circulating ligands
R. Pasqualini (1997)
Specific identification of iron oxide‐labeled stem cells using magnetic field hyperthermia and MR thermometry
D. Haddad (2012)
Theory of 1/T1 and 1/T2 NMRD profiles of solutions of magnetic nanoparticles
S. Koenig (1995)
RGD and other recognition sequences for integrins.
E. Ruoslahti (1996)
Multifunctional magnetic nanoparticles for targeted imaging and therapy.
J. Mccarthy (2008)
Introduction to Magnetic Materials
B. Cullity (1972)
Monodisperse magnetic nanoparticles for theranostic applications.
Don N. Ho (2011)
Gullick, A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor
A. A. Jungbluth (2003)
Critical enhancements of MRI contrast and hyperthermic effects by dopant-controlled magnetic nanoparticles.
Jung-tak Jang (2009)
This paper is referenced by
Properties of Cement-Based Composites Modified with Magnetite Nanoparticles: A Review
E. Horszczaruk (2019)
Cobalt Ferrite Nanoparticles Fabricated via Co-precipitation in Air: Overview of Size Control and Magnetic Properties
D. Toledo (2015)
Preparation of lysine-coated magnetic Fe2O3 nanoparticles and influence on viability of A549 lung cancer cells.
Yu-Hua Ma (2014)
Synthesis and characterization of Pt1-xPdx nanoparticles and their suitability for NH3 oxidation catalysis
Martin Jensen (2017)
Small is Smarter: Nano MRI Contrast Agents - Advantages and Recent Achievements.
Z. Gao (2016)
Noble metal-based composite nanomaterials fabricated via solution-based approaches
H. Liu (2015)
Glycine–Nitrate Process for the Elaboration of Eu3+‐Doped Gd2O3 Bimodal Nanoparticles for Biomedical Applications
G. Goglio (2015)
Cobalt Ferrite Nanoparticles Fabricated via Co-precipitation in Air : Overview of Size Control and Magnetic Properties
J. Andrian (2017)
Nanotechnology in Glycomics: Applications in Diagnostics, Therapy, Imaging, and Separation Processes
Erika Dosekova (2017)
Folic acid-conjugated magnetic ordered mesoporous carbon nanospheres for doxorubicin targeting delivery.
L. Chen (2019)
Magnetic thermosensitive core/shell microspheres: synthesis, characterization and performance in hyperthermia and drug delivery
L. Chen (2014)